Acuta Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
+485,669
| New | +$1.12M | 1.57% | 18 |
|
|
2025
Q1 | – | Sell |
-884,244
| Closed | -$1.53M | – | 44 |
|
|
2024
Q4 | $1.53M | Sell |
884,244
-1,234,748
| -58% | -$2.14M | 1.54% | 22 |
|
|
2024
Q3 | $4.26M | Sell |
2,118,992
-211,945
| -9% | -$426K | 3.45% | 10 |
|
|
2024
Q2 | $5.22M | Sell |
2,330,937
-1,002,396
| -30% | -$2.25M | 4.4% | 8 |
|
|
2024
Q1 | $9.57M | Sell |
3,333,333
-256,000
| -7% | -$735K | 6.21% | 4 |
|
|
2023
Q4 | $6.35M | Sell |
3,589,333
-238,593
| -6% | -$422K | 3.58% | 10 |
|
|
2023
Q3 | $12.1M | Buy |
+3,827,926
| New | +$12.1M | 8.11% | 1 |
|